Key result
Lifestyle and pharmacological interventions can modulate low-density lipoprotein size, but there is currently no proof that this modulation provides a clinical benefit.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Adéle Marais (2000) conducted a review in Atherosclerosis and small, dense LDL particles. Lifestyle and pharmacological intervention was evaluated. Lifestyle and pharmacological interventions can modulate low-density lipoprotein size, but there is currently no proof that this modulation provides a clinical benefit.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: